Top of page

Healthcare & Life Sciences

Industry

From investors to startups to the world’s largest healthcare companies, clients turn to us on a full range of transactions and other legal matters.

Summary

Companies appreciate our depth of experience in areas including pharmaceuticals, biotechnology, and diagnostic and medical devices. Since 2010, we have completed more than 850 capital markets transactions in healthcare, totaling over $2 trillion. Over the same period, we have advised on approximately 300 M&A transactions, with a cumulative deal value of approximately $1.4 trillion and a market share of more than 20%, according to data from LSEG Data & Analytics.

Healthcare and life sciences clients trust in our understanding of the complex issues they face in acquisitions, divestitures, joint ventures, partnerships, strategic alliances, licensing arrangements, collaborations, distribution agreements, internal investigations and litigation.

Many transactions and other matters have an intellectual property component. Clients appreciate that our team includes lawyers with strong biomedical backgrounds such as Ph.D.s and biomedical engineering degrees.

Highlight

$2+ trillion

Aggregate value of more than 850 capital markets transactions since 2010

Source: LSEG Data & Analytics

Insights

Recognition

Firm to Watch – Financial & Corporate

LMG Life Sciences Awards, 2020
Back to top